Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Villiger

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Plos Biology|June 30, 2010
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loopGediminas Matulis, Joseph P Sanderson, Nikolai M Lissin, et al.
Orphanet Journal of Rare Diseases|August 10, 2021
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, et al.
European Journal of Immunology|September 30, 2011
Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d bindingJoseph P Sanderson, Kathrin Waldburger-Hauri, Diana Garzón, et al.
The Journal of Experimental Medicine|March 8, 2006
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptorsStephan D Gadola, Michael Koch, Jon Marles-Wright, et al.
Arthritis Research & Therapy|October 26, 2018
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyUlrich A Walker, Veronika K Jaeger, Katharina M Bruppacher, et al.
Clinical and Experimental Rheumatology|July 8, 2024
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritisElisa Pesce, Mauro Bombaci, Stefania Croci, et al.
Arthritis and Rheumatism|October 31, 2007
Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trialPeter Jüni, Stephan Reichenbach, Sven Trelle, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Arthritis Research & Therapy|February 1, 2018
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupSabine Adler, Dörte Huscher, Elise Siegert, et al.
Arthritis Research & Therapy|October 15, 2023
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritisWolfgang A Schmidt, Bhaskar Dasgupta, Jennifer Sloane, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Plos Biology|June 30, 2010
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loopGediminas Matulis, Joseph P Sanderson, Nikolai M Lissin, et al.
Orphanet Journal of Rare Diseases|August 10, 2021
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, et al.
European Journal of Immunology|September 30, 2011
Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d bindingJoseph P Sanderson, Kathrin Waldburger-Hauri, Diana Garzón, et al.
The Journal of Experimental Medicine|March 8, 2006
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptorsStephan D Gadola, Michael Koch, Jon Marles-Wright, et al.
Arthritis Research & Therapy|October 26, 2018
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre studyUlrich A Walker, Veronika K Jaeger, Katharina M Bruppacher, et al.
Clinical and Experimental Rheumatology|July 8, 2024
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritisElisa Pesce, Mauro Bombaci, Stefania Croci, et al.
Arthritis and Rheumatism|October 31, 2007
Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trialPeter Jüni, Stephan Reichenbach, Sven Trelle, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Arthritis Research & Therapy|February 1, 2018
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR groupSabine Adler, Dörte Huscher, Elise Siegert, et al.
Arthritis Research & Therapy|October 15, 2023
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritisWolfgang A Schmidt, Bhaskar Dasgupta, Jennifer Sloane, et al.
Pageof 14